VIKING GLOBAL INVESTORS LP - BRIDGEBIO PHARMA INC ownership

BRIDGEBIO PHARMA INC's ticker is BBIO and the CUSIP is 10806X102. A total of 171 filers reported holding BRIDGEBIO PHARMA INC in Q2 2022. The put-call ratio across all filers is 0.46 and the average weighting 0.3%.

Quarter-by-quarter ownership
VIKING GLOBAL INVESTORS LP ownership history of BRIDGEBIO PHARMA INC
ValueSharesWeighting
Q3 2023$662,440,533
+44.7%
25,120,991
-5.6%
2.69%
+43.4%
Q2 2023$457,881,045
+3.7%
26,620,9910.0%1.88%
-9.5%
Q1 2023$441,376,031
+117.6%
26,620,9910.0%2.07%
+104.0%
Q4 2022$202,851,951
-23.3%
26,620,9910.0%1.02%
-16.9%
Q3 2022$264,613,000
+9.5%
26,620,9910.0%1.22%
+10.5%
Q2 2022$241,719,000
-10.5%
26,620,9910.0%1.11%
+1.3%
Q1 2022$270,203,000
-39.1%
26,620,9910.0%1.09%
-14.6%
Q4 2021$444,038,000
-64.4%
26,620,9910.0%1.28%
-62.6%
Q3 2021$1,247,726,000
-23.1%
26,620,9910.0%3.42%
-30.4%
Q2 2021$1,622,816,000
-1.0%
26,620,9910.0%4.92%
+0.7%
Q1 2021$1,639,853,000
-13.4%
26,620,9910.0%4.88%
-6.2%
Q4 2020$1,893,019,000
+89.5%
26,620,9910.0%5.20%
+44.2%
Q3 2020$998,820,000
+15.1%
26,620,9910.0%3.61%
-3.8%
Q2 2020$868,111,000
+12.4%
26,620,9910.0%3.75%
-6.6%
Q1 2020$772,009,000
-17.3%
26,620,9910.0%4.02%
-8.1%
Q4 2019$933,066,000
+63.3%
26,620,9910.0%4.37%
+46.7%
Q3 2019$571,553,000
-20.4%
26,620,9910.0%2.98%
-7.6%
Q2 2019$717,968,00026,620,9913.22%
Other shareholders
BRIDGEBIO PHARMA INC shareholders Q2 2022
NameSharesValueWeighting ↓
Aisling Capital Management LP 6,068,125$100,609,51348.41%
Kohlberg Kravis Roberts & Co. L.P. 31,060,971$514,990,89915.50%
M28 Capital Management LP 304,700$5,051,9265.71%
Cormorant Asset Management, LP 4,557,414$75,5624.98%
Octagon Capital Advisors LP 1,338,160$22,186,6933.19%
Ikarian Capital, LLC 594,686$9,859,8942.24%
Affinity Asset Advisors, LLC 389,800$6,462,8842.13%
VIKING GLOBAL INVESTORS LP 26,620,991$441,376,0312.07%
Ikarian Capital, LLC 549,600$9,112,3682.07%
Affinity Asset Advisors, LLC 320,000$5,305,6001.75%
View complete list of BRIDGEBIO PHARMA INC shareholders